CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Naltrexone 25mg +1 moredrug
Likely dose
Naltrexone 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00793780
NCT00793780N/ACompleted
CompareCT.gov

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Yale University·interventional·Posted Nov 19, 2008·Updated Oct 6, 2016

In Brief

A clinical study evaluating Naltrexone 25mg and Placebo for Obesity and 2 related conditions. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this clinical trial is to find out how effective low dose oral naltrexone is on reducing body weight when compared to placebo in women with schizophrenia and schizoaffective disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Schizophrenia, Schizoaffective Disorder
CountriesUnited States
CollaboratorsEthel F. Donaghue Women's Health Investigator Program at Yale

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2008
Enrollment StartDec 1, 2008
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.6 years ago

Interventions

Naltrexone 25mgdrug

Naltrexone 25mg caplets taken orally once a day for 8 weeks

Placeboother

Placebo caplet (inactive substance) taken orally once a day for 8 weeks